KOMBOGLYZE 2,5 mg/1000 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium de 60 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400922007892
  • CIP7 2200789
  • CIS 68674913
  • Registration number EU/1/11/731

What the source publishes

Holder
ASTRAZENECA AB
Active ingredients
CHLORHYDRATE DE METFORMINE, SAXAGLIPTINE, CHLORHYDRATE DE SAXAGLIPTINE
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) aluminium de 60 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2011-11-24
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400922007892
{
  "cis": "68674913",
  "cip7": "2200789",
  "form": "comprimé pelliculé",
  "name": "KOMBOGLYZE 2,5 mg/1000 mg, comprimé pelliculé — plaquette(s) thermoformée(s) aluminium de 60 comprimé(s)",
  "cip13": "3400922007892",
  "holder": "ASTRAZENECA AB",
  "routes": [
    "orale"
  ],
  "holders": [
    "ASTRAZENECA AB"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "15.04",
  "authorisedOn": "2011-11-24",
  "compositions": [
    {
      "name": "CHLORHYDRATE DE METFORMINE",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "2",
      "substanceCode": "24321",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "SAXAGLIPTINE",
      "nature": "FT",
      "strength": "2,5 mg",
      "linkageNumber": "1",
      "substanceCode": "27375",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE SAXAGLIPTINE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "45154",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "14.02",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "KOMBOGLYZE 2,5 mg/1000 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) thermoformée(s) aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "15 %"
  ],
  "marketingDeclaredOn": "2026-01-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE DE METFORMINE",
    "SAXAGLIPTINE",
    "CHLORHYDRATE DE SAXAGLIPTINE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/11/731",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400922007892"